Bank of America’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.3K | Sell |
7,443
-1,621
| -18% | -$2.03K | ﹤0.01% | 6183 |
|
2025
Q1 | $29.3K | Sell |
9,064
-5,649
| -38% | -$18.2K | ﹤0.01% | 5855 |
|
2024
Q4 | $60.6K | Buy |
14,713
+10,880
| +284% | +$44.8K | ﹤0.01% | 5690 |
|
2024
Q3 | $24.6K | Buy |
3,833
+1,443
| +60% | +$9.26K | ﹤0.01% | 5800 |
|
2024
Q2 | $11.5K | Buy |
+2,390
| New | +$11.5K | ﹤0.01% | 5986 |
|